BioCatch, the global leader in Behavioral Authentication and Malware Detection, today announced the appointment of two new members to the company’s Board of Directors: Gadi Maier, who will serve as the board’s Chairman, and Howard Edelstein, who will serve as an independent director.
Mr. Maier is a FinTech industry expert with many years of successful innovation and leadership under his belt, including at Currenex, which he founded and sold to State Street Bank for $564 million; FraudScience, acquired by eBay in 2008 for $169 million; and Finjan Software, a provider of enterprise web security systems that is now part of M86 Security. A longtime technology innovator and investor, Mr. Maier was a Venture Partner at Benchmark Capital early in his career and is currently founder and CEO of FMN Technologies, a San Francisco Bay Area software firm.
Mr. Edelstein brings to BioCatch a celebrated history of building and transforming financial technology companies. Recognized as an innovator and industry thought leader for more than two decades, Edelstein was honored as one of 15 “Industry Luminaries” by Waters Magazine in 2008 and as a “Legend” of the Securities Services Industry in 2009 by Global Custodian Magazine for his role in shaping today’s industry. This past year he was named as one of the 40 Leading Innovators in Trading Technology by Institutional Investor Magazine.
BioCatch investors include OurCrowd, Blumberg Capital, and Janvest. Additional board members include company co-founder and CTO, Avi Turgeman; Bruce Taragin, managing director of Blumberg Capital; David Assia, Executive Chairman of iAngels; Felix Zilberstein, managing partner of Janvest and Pini Lozowick, general partner at OurCrowd.
“I am excited to join the BioCatch Board,” said Gadi Maier. “BioCatch is already playing a major role in protecting banks and ecommerce from the growing threats of identities theft and remote access attacks on digital channels. Recent evidence has shown that these threats are expanding to the booming world of peer to peer payments. Using sophisticated biometric technology, BioCatch has the only proven capability of preventing this type of costly threat wherever it manifests itself.”
“There are few opportunities to disrupt the authentication industry and the potential that is offered by behavioral biometrics is limitless,” added Howard Edelstein. “I am pleased to formalize the relationship and look forward to helping the company expand its product and market access.”